US Stock MarketDetailed Quotes

BCRX BioCryst Pharmaceuticals

Watchlist
  • 7.380
  • -0.120-1.60%
Close Dec 2 16:00 ET
  • 7.270
  • -0.110-1.49%
Post 20:01 ET
1.53BMarket Cap-12098P/E (TTM)

BioCryst Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
34.98%117.09M
32.54%109.33M
34.87%92.76M
22.37%331.41M
17.42%93.4M
14.39%86.74M
25.88%82.49M
37.77%68.78M
72.31%270.83M
68.68%79.55M
Operating revenue
35.75%116.32M
32.54%109.33M
34.87%92.76M
22.37%331.41M
21.07%96.31M
13.00%85.68M
25.88%82.49M
38.38%68.78M
72.31%270.83M
68.68%79.55M
Cost of revenue
184.15%3.23M
82.53%1.73M
48.40%1.39M
-29.31%4.66M
-34.42%1.64M
-68.56%1.14M
284.62%950K
294.12%938K
-9.22%6.59M
495.70%2.5M
Gross profit
33.00%113.86M
31.96%107.6M
34.68%91.37M
23.66%326.75M
19.10%91.76M
18.54%85.61M
24.90%81.54M
36.54%67.84M
76.27%264.23M
64.85%77.05M
Operating expense
8.86%106.17M
-3.33%98.84M
9.98%105.86M
4.31%430.46M
8.98%134.43M
8.78%97.53M
2.24%102.24M
-3.40%96.26M
25.96%412.67M
24.71%123.36M
Selling and administrative expenses
28.50%65.08M
20.03%61.21M
24.02%59.36M
34.21%213.89M
28.37%64.38M
37.19%50.65M
34.14%51M
39.63%47.87M
34.13%159.37M
41.73%50.15M
Research and development costs
-12.37%41.08M
-26.58%37.62M
-3.92%46.49M
-14.50%216.57M
-4.31%70.05M
-11.11%46.88M
-17.33%51.25M
-25.97%48.39M
21.31%253.3M
15.23%73.21M
Operating profit
164.52%7.69M
142.32%8.76M
49.01%-14.49M
30.13%-103.71M
7.86%-42.67M
31.67%-11.92M
40.37%-20.7M
43.12%-28.42M
16.48%-148.44M
11.24%-46.31M
Net non-operating interest income expense
8.31%-21.24M
15.84%-21.18M
14.75%-20.48M
1.60%-92.46M
15.31%-20.12M
-0.63%-23.16M
-7.48%-25.17M
-0.99%-24.02M
-58.64%-93.97M
-26.58%-23.75M
Non-operating interest income
-14.17%3.59M
-5.23%3.55M
19.33%4.03M
207.72%15.78M
65.13%4.47M
137.73%4.18M
515.76%3.75M
6,155.56%3.38M
8,169.35%5.13M
19,214.29%2.7M
Non-operating interest expense
-9.20%24.83M
-14.46%24.73M
-10.55%24.51M
9.23%108.24M
-7.09%24.58M
10.37%27.35M
20.37%28.92M
14.93%27.4M
67.12%99.09M
40.88%26.46M
Other net income (expense)
113.30%98K
99.71%-84K
77.73%-51K
-1,415.78%-30.06M
73.29%-374K
-36.99%-737K
-21,856.06%-28.72M
-29.38%-229K
-103.60%-1.98M
-102.53%-1.4M
Gain on sale of security
113.30%98K
-127.91%-84K
77.73%-51K
47.60%-1.04M
73.29%-374K
-36.99%-737K
128.03%301K
-29.38%-229K
-185.32%-1.98M
-232.54%-1.4M
Special income (charges)
--0
--0
----
---29.02M
--0
--0
---29.02M
----
--0
--0
-Less:Other special charges
----
----
----
--29.02M
--0
----
--29.02M
----
----
----
Income before tax
62.46%-13.45M
83.24%-12.5M
33.51%-35.01M
7.43%-226.23M
11.62%-63.16M
12.63%-35.82M
-28.59%-74.59M
28.76%-52.66M
-34.42%-244.38M
-360.29%-71.47M
Income tax
77.58%586K
-76.76%172K
-45.60%365K
-88.66%310K
-1,982.89%-1.43M
-78.32%330K
-13.55%740K
140.50%671K
21.30%2.73M
-96.63%76K
Net income
61.18%-14.03M
83.17%-12.67M
33.66%-35.38M
8.33%-226.54M
13.71%-61.73M
14.98%-36.15M
-27.98%-75.33M
28.12%-53.33M
-34.26%-247.12M
-302.39%-71.54M
Net income continuous Operations
61.18%-14.03M
83.17%-12.67M
33.66%-35.38M
8.33%-226.54M
13.71%-61.73M
14.98%-36.15M
-27.98%-75.33M
28.12%-53.33M
-34.26%-247.12M
-302.39%-71.54M
Minority interest income
Net income attributable to the parent company
61.18%-14.03M
83.17%-12.67M
33.66%-35.38M
8.33%-226.54M
13.71%-61.73M
14.98%-36.15M
-27.98%-75.33M
28.12%-53.33M
-34.26%-247.12M
-302.39%-71.54M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
61.18%-14.03M
83.17%-12.67M
33.66%-35.38M
8.33%-226.54M
13.71%-61.73M
14.98%-36.15M
-27.98%-75.33M
28.12%-53.33M
-34.26%-247.12M
-302.39%-71.54M
Basic earnings per share
63.16%-0.07
85.00%-0.06
39.29%-0.17
11.28%-1.18
18.42%-0.31
17.39%-0.19
-25.00%-0.4
30.00%-0.28
-29.13%-1.33
-280.00%-0.38
Diluted earnings per share
63.16%-0.07
85.00%-0.06
39.29%-0.17
11.28%-1.18
18.42%-0.31
17.39%-0.19
-25.00%-0.4
30.00%-0.28
-29.13%-1.33
-280.00%-0.38
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 34.98%117.09M32.54%109.33M34.87%92.76M22.37%331.41M17.42%93.4M14.39%86.74M25.88%82.49M37.77%68.78M72.31%270.83M68.68%79.55M
Operating revenue 35.75%116.32M32.54%109.33M34.87%92.76M22.37%331.41M21.07%96.31M13.00%85.68M25.88%82.49M38.38%68.78M72.31%270.83M68.68%79.55M
Cost of revenue 184.15%3.23M82.53%1.73M48.40%1.39M-29.31%4.66M-34.42%1.64M-68.56%1.14M284.62%950K294.12%938K-9.22%6.59M495.70%2.5M
Gross profit 33.00%113.86M31.96%107.6M34.68%91.37M23.66%326.75M19.10%91.76M18.54%85.61M24.90%81.54M36.54%67.84M76.27%264.23M64.85%77.05M
Operating expense 8.86%106.17M-3.33%98.84M9.98%105.86M4.31%430.46M8.98%134.43M8.78%97.53M2.24%102.24M-3.40%96.26M25.96%412.67M24.71%123.36M
Selling and administrative expenses 28.50%65.08M20.03%61.21M24.02%59.36M34.21%213.89M28.37%64.38M37.19%50.65M34.14%51M39.63%47.87M34.13%159.37M41.73%50.15M
Research and development costs -12.37%41.08M-26.58%37.62M-3.92%46.49M-14.50%216.57M-4.31%70.05M-11.11%46.88M-17.33%51.25M-25.97%48.39M21.31%253.3M15.23%73.21M
Operating profit 164.52%7.69M142.32%8.76M49.01%-14.49M30.13%-103.71M7.86%-42.67M31.67%-11.92M40.37%-20.7M43.12%-28.42M16.48%-148.44M11.24%-46.31M
Net non-operating interest income expense 8.31%-21.24M15.84%-21.18M14.75%-20.48M1.60%-92.46M15.31%-20.12M-0.63%-23.16M-7.48%-25.17M-0.99%-24.02M-58.64%-93.97M-26.58%-23.75M
Non-operating interest income -14.17%3.59M-5.23%3.55M19.33%4.03M207.72%15.78M65.13%4.47M137.73%4.18M515.76%3.75M6,155.56%3.38M8,169.35%5.13M19,214.29%2.7M
Non-operating interest expense -9.20%24.83M-14.46%24.73M-10.55%24.51M9.23%108.24M-7.09%24.58M10.37%27.35M20.37%28.92M14.93%27.4M67.12%99.09M40.88%26.46M
Other net income (expense) 113.30%98K99.71%-84K77.73%-51K-1,415.78%-30.06M73.29%-374K-36.99%-737K-21,856.06%-28.72M-29.38%-229K-103.60%-1.98M-102.53%-1.4M
Gain on sale of security 113.30%98K-127.91%-84K77.73%-51K47.60%-1.04M73.29%-374K-36.99%-737K128.03%301K-29.38%-229K-185.32%-1.98M-232.54%-1.4M
Special income (charges) --0--0-------29.02M--0--0---29.02M------0--0
-Less:Other special charges --------------29.02M--0------29.02M------------
Income before tax 62.46%-13.45M83.24%-12.5M33.51%-35.01M7.43%-226.23M11.62%-63.16M12.63%-35.82M-28.59%-74.59M28.76%-52.66M-34.42%-244.38M-360.29%-71.47M
Income tax 77.58%586K-76.76%172K-45.60%365K-88.66%310K-1,982.89%-1.43M-78.32%330K-13.55%740K140.50%671K21.30%2.73M-96.63%76K
Net income 61.18%-14.03M83.17%-12.67M33.66%-35.38M8.33%-226.54M13.71%-61.73M14.98%-36.15M-27.98%-75.33M28.12%-53.33M-34.26%-247.12M-302.39%-71.54M
Net income continuous Operations 61.18%-14.03M83.17%-12.67M33.66%-35.38M8.33%-226.54M13.71%-61.73M14.98%-36.15M-27.98%-75.33M28.12%-53.33M-34.26%-247.12M-302.39%-71.54M
Minority interest income
Net income attributable to the parent company 61.18%-14.03M83.17%-12.67M33.66%-35.38M8.33%-226.54M13.71%-61.73M14.98%-36.15M-27.98%-75.33M28.12%-53.33M-34.26%-247.12M-302.39%-71.54M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 61.18%-14.03M83.17%-12.67M33.66%-35.38M8.33%-226.54M13.71%-61.73M14.98%-36.15M-27.98%-75.33M28.12%-53.33M-34.26%-247.12M-302.39%-71.54M
Basic earnings per share 63.16%-0.0785.00%-0.0639.29%-0.1711.28%-1.1818.42%-0.3117.39%-0.19-25.00%-0.430.00%-0.28-29.13%-1.33-280.00%-0.38
Diluted earnings per share 63.16%-0.0785.00%-0.0639.29%-0.1711.28%-1.1818.42%-0.3117.39%-0.19-25.00%-0.430.00%-0.28-29.13%-1.33-280.00%-0.38
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data